Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The goal of this clinical trial is to evaluate the efficacy, safety, and tolerability of linsitinib in participants with moderate to severe Thyroid Eye Disease (TED).
Epistemonikos ID: 7df48d9a7851956a027fa9a8a6891bb10f38b479
First added on: Aug 08, 2026